Author:
Nguyen K. T.,Lee P. P.,Yock P. G.,Tan N. C.,Tan H. K.,Lee W. T.
Reference22 articles.
1. Yock, P., Zenios, S., Makower, J., et al.: Biodesign, 2nd edn. Cambridge University Press, UK (2015)
2. Solomon, N.A., Glick, H.A., Russo, C.J., Lee, J., Schulman, K.A.: Patient preferences for stroke outcomes. Stroke 25(9), 1721–1725 (1994)
3. Troke, S.T.S., Roup, S.T.G.: Tissue plasminogen activator for acute ischemic stroke. N. Engl. J. Med. 231(16), 1240–1241 (1999)
4. Fonarow, G.C., Smith, E.E., Reeves, M.J., Grau-sepulveda, M.V., Hernandez, A.F., Peterson, E.D., Schwamm, L.H.: Time to treatment with intravenous tissue plasminogen activator and outcome from acute ischemic stroke. JAMA 309(23), 2480–2488 (2013)
5. Saver, J.L., Goyal, M., van der Lugt, A., Menon, B.K., Majoie, C.B.L.M., Dippel, D.W.: Time to treatment with endovascular thrombectomy and outcomes from ischemic stroke: a meta-analysis. JAMA 316(12), 1279 (2016)